As an engineer, Subra Suresh has made a career of studying stress and fatigue: from aluminium alloys in planes and silicon wafers in chips, to the walls of cells infected with malaria. As the man nominated by Barack Obama's administration to head the US National Science Foundation (NSF), Suresh may soon find himself as challenged as the materials in his lab, as the agency competes for cash in an increasingly austere budget climate.
If confirmed, Suresh is likely to encounter politics in spades. The stimulus funding that was a windfall for the NSF last year came alongside a whopping 6.2% rise in regular agency funding for fiscal year 2010. As a result, the NSF made a record number of research grants, using stimulus funds to boost the acceptance rate for a backlog of qualified proposals. But that rate will drop as the stimulus money peters out, says Rankin.
Congress is unlikely to set the NSF's budget until after the midterm elections in November, which means funding could be frozen at 2010 levels well into next year. With concerns about the national debt rising, observers say that when Congress does act, the agency will be lucky to get half of the 8% budget increase that was requested by the White House in February.
■
Eric Hand engineer set to run nsF Disease Research and Policy in Minneapolis, points out that the 2004 document was based on input from an international panel of 22 scientists and public-health officials, in response to the threat of the deadly H5N1 avian flu virus. "To suggest that the three scientists were able to direct and control the final recommendations is naive, and stated without a single shred of evidence, " he says.
The BMJ also claims that industry funding of the European Scientific Working Group on Influenza (ESWI), a group of flu scientists that provided advice to the WHO, presented a "potential conflict of interest". It notes that several ESWI scientists also receive industry funding directly.
One of those scientists is Albert Osterhaus, a virologist at Erasmus Medical Centre in Rotterdam in the Netherlands, who chairs the ESWI. He says that the body has a "clear firewall" with its funders, and that it informs all partners about any of its competing interests -its sources of funding are also listed on its website. Privatepublic partnerships are essential in tackling pandemics, and excluding flu researchers with industry links would deprive advisory panels of world-class expertise, he says. "The critical thing is transparency, " says Osterhaus. "I have always declared my own competing interests. "
The BMJ acknowledges that the researchers had declared their interests elsewhere. But it takes issue with the WHO's not having included them in its pandemic-planning documents.
David Ozonoff, an epidemiologist at the Boston University School of Public Health in Massachusetts, says that the reports "smear" the scientists involved in pandemic planning by "insinuating" that they would have offered different advice had they not had a relationship with drug companies. "This is a pretty serious charge, " he says.
"We think this is the researcher's reading into it, not necessarily ours, " the BMJ authors respond.
Marc Lipsitch, an epidemiologist at Harvard School of Public Health in Boston, Massachusetts, says that the WHO's advice on the pandemic has been sound, and has reflected the state of scientific opinion. Comparing the situation with the ongoing Deepwater Horizon oil spill, Lipsitch says that "it is ironic, as we watch for the second time in five years the catastrophic results of 'best-case scenario planning' in the Gulf of Mexico, to have the WHO coming under criticism for planning for, and raising awareness of, the possibility of a severe pandemic. That is what public-health agencies should do, and what most did in this instance, and they should be commended for it. " 
